Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 209.29 Bn | 205.35 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 137.39 Bn | 133.06 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.84 Bn | 46.64 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.29 Bn | 37.48 Bn | 990.00 Mn | 57.67% |
| 5 | Natera | 39.28 Bn | 38.18 Bn | 696.04 Mn | -27.15% |
| 6 | Iqvia Holdings | 37.90 Bn | 35.95 Bn | 1.44 Bn | -9.74% |
| 7 | Illumina | 30.65 Bn | 29.49 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.92 Bn | 28.87 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 25.96 Bn | 25.64 Bn | 1.03 Bn | 12.89% |
| 10 | Labcorp Holdings | 25.71 Bn | 24.73 Bn | 1.01 Bn | 30.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 8.66% |
| Mar 28, 2026 | 10.42% |
| Dec 31, 2025 | 9.29% |
| Sep 27, 2025 | -0.67% |
| Jun 28, 2025 | 4.46% |
| Mar 29, 2025 | 13.48% |
| Dec 31, 2024 | 12.27% |
| Sep 28, 2024 | -4.96% |
| Jun 29, 2024 | 13.74% |
| Mar 30, 2024 | 3.03% |
| Dec 31, 2023 | 3.43% |
| Sep 30, 2023 | 14.72% |
| Jul 1, 2023 | -18.21% |
| Apr 1, 2023 | -41.81% |
| Dec 31, 2022 | -4.95% |
| Oct 1, 2022 | -21.40% |
| Jul 2, 2022 | -8.97% |
| Apr 2, 2022 | -5.22% |
| Dec 31, 2021 | -33.63% |
| Oct 2, 2021 | -1.60% |